Sablich Kim
SEC CIK 1758790 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| JAZZ | Jazz Pharmaceuticals plc | EVP, GM, North America | 28.5K | — | $1.37M | 9 | 2021-11-11 | 2023-06-05 |
Most active insiders at JAZZ, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | COZADD BRUCE C | Dir | — | $27.15M |
| 2 | Iannone Robert | EVP, CMO, Gbl Head of R, D | — | $20.41M |
| 3 | Patil Neena M | EVP, CLO | — | $11.50M |
| 4 | Carr Patricia | SVP, CAO | — | $2.46M |
| 5 | Winningham Rick E | Dir | — | $1.66M |
| 6 | Pearce Samantha | EVP, Chief Commercial Off | — | $1.63M |
| 7 | Henderson Mary Elizabeth | SVP, Technical Ops | — | $1.42M |
| 8 | McSharry Heather Ann | Dir | — | $1.09M |
| 9 | RIEDEL NORBERT G | Dir | — | $655.7K |
| 10 | GALA RENEE D | Pres, CEO | — | $486.1K |
Sablich Kim made no open-market trades at JAZZ in the last 12 months.
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-07 | 2023-06-05 | JAZZ | Jazz Pharmaceuticals plc | Sablich Kim | EVP, GM of U.S | D - Sale to Iss | $129.73 | -2,082 | 28.5K | -7% | -$270.1K | |
| M | 2023-03-10 | 2023-03-08 | JAZZ | Jazz Pharmaceuticals plc | Sablich Kim | EVP, GM of U.S, Commercial Ma | S - Sale | $139.74 | -3,013 | 31.8K | -9% | -$421.0K |
| 2023-03-07 | 2023-03-05 | JAZZ | Jazz Pharmaceuticals plc | Sablich Kim | EVP, GM of U.S, Commercial Ma | F - Tax | $142.78 | -1,610 | 33.6K | -5% | -$229.9K | |
| 2023-03-07 | 2023-03-03 | JAZZ | Jazz Pharmaceuticals plc | Sablich Kim | EVP, GM of U.S, Commercial Ma | A - Grant | $0.00 | +10.4K | 35.2K | +42% | $0 | |
| M | 2022-06-08 | 2022-06-06+ | JAZZ | Jazz Pharmaceuticals plc | Sablich Kim | EVP, GM, North America | S - Sale | $151.45 | -3,829 | 26.7K | -13% | -$579.9K |
| 2022-06-08 | 2022-06-06 | JAZZ | Jazz Pharmaceuticals plc | Sablich Kim | EVP, GM, North America | F - Tax | $149.25 | -1,759 | 28.6K | -6% | -$262.5K | |
| 2022-03-09 | 2022-03-05 | JAZZ | Jazz Pharmaceuticals plc | Sablich Kim | EVP, GM, North America | F - Tax | $153.96 | -746 | 30.3K | -2% | -$114.9K | |
| 2022-03-09 | 2022-03-03 | JAZZ | Jazz Pharmaceuticals plc | Sablich Kim | EVP, GM, North America | A - Grant | $0.00 | +9,953 | 31.1K | +47% | $0 | |
| 2021-11-15 | 2021-11-11 | JAZZ | Jazz Pharmaceuticals plc | Sablich Kim | EVP, GM, North America | S - Sale | $135.01 | -2,748 | 21.1K | -12% | -$371.0K |
Purchase Sale Sale after option exercise All abbreviations